Biorbyt News
Royal representative presents Biorbyt with Queen's Award
Biorbyt is proud to have been presented a Queen’s Award for Enterprise in International Trade during a visit from Mrs Julie Spence, OBE, QPM, Her Majesty’s Lord-Lieutenant of Cambridgeshire. Accompanied by Deputy Lieutenant Penelope Walkinshaw, and Sgt Maj Rhyder Cameron-Wickes, Lord-Lieutenant’s Cadet, this celebration started with the distinguished guests enjoying a tour of the company’s premises and learning about Biorbyt’s history and its role in life sciences research. This was followed by speeches from the Lord-Lieutenant and Deputy Lieutenant, and the presentation of the prestigious crystal Queen’s Award trophy. After the ceremony, the royal representatives met members of the Biorbyt team while enjoying refreshments.Find out more
15th December 2021
Jack Cooper: Ditching the lab coat to help others
KDM Communications chat with Jack Cooper, who has emerged from the lab to establish himself as a product manager at Biorbyt, combining his wealth of scientific knowledge with his interpersonal skills to benefit customers. Read the article
24th September 2021
Biorbyt are Queen's Award for Enterprise Winners 2021
We are immensely proud recipients of the Queen's Award for Enterprise: International Trade. This is a tremendous accolade and testament to all the hard work our team has done over the last decade. What an incredible way to celebrate our 10th year anniversary!
29th April 2021
Celebrating our 10th Year Anniversary
2021 is a very special year for Biorbyt as we celebrate our tenth year. As a company, we are proud to serve a satisfied customer base. As an employer, we are excited to create a global business that supports, challenges, and nurtures talent. As a small business, we are part of a network of companies that support each other.
10th January 2021
Qun Yang sharing her experience and research
Qun Yang, co-founder of Biorbyt, and Christopher R. Lowe, from the University of Cambridge, talk about antibody testing and how the scientific community has risen to the challenge posed by Covid-19. Watch it here
1st September 2020
Siân Bolitho providing scientific insight
Siân Bolitho, Commercial Manager at Biorbyt, recently interviewed by Biocompare giving expert advice on optimizing immunoassay design and validation. Read more
24th August 2020
Biorbyt donates to Addenbrooke's
Biorbyt has recently donated 50 goggles and 50 coverall suits to Addenbrooke's Hospital.
14th July 2020
Qun Yang talking with ICAEW
Read how Qun Yang, co-founder of Biorbyt, is accelerating the company's adapting action to overcome the challenges COVID-19 has presented. Read more
21st May 2020
Biorbyt on CGTN FRANÇAIS
A French news report on the importance of communication between Europe and China in the fight against CoVid-19. Biorbyt and other Cambridge start-ups are at the front line in helping the research on Coronavirus. Cambridge is world-renowned for its scientific excellence and Biorbyt are collaborating with Crayfish.io who offer a translating platform to facilitate the collaboration between China and the UK. This helps Biorbyt's provision of antibodies to research institutes around the world.
Qun Yang, co-founder of Biorbyt, says:
"The only way to get out of this crisis is by doing research in order to gain a better understanding of the virus."
1st May 2020
Coronavirus Research Products
We have a useful array of products to help with your Coronavirus research.
Our range include primary antibodies and antigens, Small Molecules, ELISA Kits and Proteins for:
|
|
29st April 2020
Biorbyt on BBC Look East
Commercial Manager Siân Bolitho discusses Biorbyt's role in supplying antibodies for the Coronavirus outbreak. Ting Zhang from Crayfish discusses how her translation software enables a more efficient workflow for Biorbyt.
Siân says:
"We’ve started by using antibodies to very closely-related viruses...the SARS and the MERS from previous outbreaks...and we’ve looked at the sequences that were very quickly generated by Chinese scientists who sequenced the virus themselves, and they’re developing assays, they’re researching into how the virus mutates, how the virus is transmitted, and they’re looking to find a cure."
3rd March 2020
